Genelux Statistics
Total Valuation
Genelux has a market cap or net worth of $86.96 million. The enterprise value is $54.94 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Genelux has 34.10 million shares outstanding. The number of shares has increased by 47.42% in one year.
Current Share Class | 34.10M |
Shares Outstanding | 34.10M |
Shares Change (YoY) | +47.42% |
Shares Change (QoQ) | +16.31% |
Owned by Insiders (%) | 17.11% |
Owned by Institutions (%) | 15.49% |
Float | 25.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.66 |
P/TBV Ratio | 2.63 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 6,867.81 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.47, with a Debt / Equity ratio of 0.06.
Current Ratio | 6.47 |
Quick Ratio | 6.13 |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -96.85% and return on invested capital (ROIC) is -59.27%.
Return on Equity (ROE) | -96.85% |
Return on Assets (ROA) | -48.68% |
Return on Capital (ROIC) | -59.27% |
Revenue Per Employee | $348 |
Profits Per Employee | -$1.20M |
Employee Count | 23 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.43% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -75.43% |
50-Day Moving Average | 2.64 |
200-Day Moving Average | 3.49 |
Relative Strength Index (RSI) | 44.80 |
Average Volume (20 Days) | 186,527 |
Short Selling Information
The latest short interest is 1.43 million, so 4.20% of the outstanding shares have been sold short.
Short Interest | 1.43M |
Short Previous Month | 1.04M |
Short % of Shares Out | 4.20% |
Short % of Float | 5.56% |
Short Ratio (days to cover) | 8.90 |
Income Statement
In the last 12 months, Genelux had revenue of $8,000 and -$27.66 million in losses. Loss per share was -$0.94.
Revenue | 8,000 |
Gross Profit | 8,000 |
Operating Income | -28.95M |
Pretax Income | -25.78M |
Net Income | -27.66M |
EBITDA | -28.68M |
EBIT | -28.95M |
Loss Per Share | -$0.94 |
Full Income Statement Balance Sheet
The company has $34.06 million in cash and $2.04 million in debt, giving a net cash position of $32.02 million or $0.94 per share.
Cash & Cash Equivalents | 34.06M |
Total Debt | 2.04M |
Net Cash | 32.02M |
Net Cash Per Share | $0.94 |
Equity (Book Value) | 33.09M |
Book Value Per Share | 0.96 |
Working Capital | 30.41M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$23.84 million and capital expenditures -$528,000, giving a free cash flow of -$24.36 million.
Operating Cash Flow | -23.84M |
Capital Expenditures | -528,000 |
Free Cash Flow | -24.36M |
FCF Per Share | -$0.71 |
Full Cash Flow Statement Margins
Gross Margin | 100.00% |
Operating Margin | -361,862.50% |
Pretax Margin | -345,750.00% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -262,312.50% |